Mayo Clinic Selects Complete Genomics to Provide Outsourced Whole Genome Sequencing
February 13, 2012
MOUNTAIN VIEW, Calif., Genomics Inc. (NASDAQ: GNOM) announced today that it has been selected by Mayo Clinic’s Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics’ sequencing service for some of its large-scale whole genome sequencing projects. The Center for Individualized Medicine [...]
TIBCO Spotfire and Chemaxon to Deliver Integrated Solution for Chemical Science Community
February 13, 2012
SOMERVILLE, Mass., and BUDAPEST, Hungary, TIBCO Software Inc. (NASDAQ: TIBX) and ChemAxon, a leader in providing chemical software development platforms and desktop applications for the biotechnology and pharmaceutical industries, today announced the full integration of the TIBCO Spotfire® Analytics Platform with ChemAxon's Instant JChem data management application. Through this integration, new levels of visualization, analysis [...]
February 13, 2012
GAITHERSBURG, Md., MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, is hosting a series of events at Informa’s Cell Line Development and Engineering Meeting 2012 being held February 13-17 at the Radisson Blu Hotel in Cologne, Germany. “Rapid production of high titer proteins in large volumes using scalable, transient transfection of mammalian [...]
CLC bio part of €12M EU grant to uncover the mechanisms that determine cell fate
February 13, 2012
Today European scientists are meeting to kick off the 4DCellFate project, funded by the European Commission under the FP7 program. The 4DcellFate project will tackle the question of how the Polycomb Repressive Complex (PRC) and Nucleosome Remodelling and histone Deacetylase (NuRD) complexes function across the genome and time during differentiation, by applying cutting- edge technologies, [...]
Tecan appoints Dr David Martyr new Chief Executive Officer
February 13, 2012
Männedorf, Switzerland, The Tecan Group (SIX Swiss Exchange: TECN) today announced that the Board of Directors has appointed Dr David Martyr as Chief Executive Officer of the Company. He will join the company as soon as his current contractual obligations permit, but no later than October 8, 2012. As announced on October 7, 2011, the [...]
February 13, 2012
IRVINE, Calif., CombiMatrix Corporation, a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that one of the nation's leading clinicians in the field of reproductive genetics has called for chromosomal microarray testing to replace karyotyping, the historic practice, as the standard of care for prenatal testing. CombiMatrix is one [...]
Eppendorf Licenses Technology for Thermal Cyclers to Agilent
February 13, 2012
HAMBURG, Germany, Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to Agilent Technologies, including US patent Nos. 6,767,512 and 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler® pro gradient, Mastercycler nexus gradient and Mastercycler ep realplex models. Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes instruments and consumables for [...]
Provides Automation Platform to Offer Integrated Microbiology Lab Solutions
February 13, 2012
FRANKLIN LAKES, N.J., BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired KIESTRA Lab Automation BV, a Netherlands-based company that designs, develops, manufactures, markets and sells innovative lab automation solutions for the microbiology lab. The financial terms of the acquisition were not disclosed. The transaction [...]
SeraCare Announces Definitive Agreement to be Acquired by Linden Capital Partners
February 13, 2012
MILFORD, Mass., SeraCare Life Sciences, Inc., a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners, a Chicago-based private equity firm that focuses [...]
CDEX Inc. Commences Debt Restructuring to Strengthen Company’s Future Competitiveness
February 10, 2012
TUCSON, AZ, CDEX Inc. today announced that to achieve a debt structure that would allow the Company to continue to develop its leading edge products in the healthcare markets with the ValiMed G4 medication safety system and in the security market with its ID2 Meth Scanner and Pocket ID2 Meth Scanner it has retained the [...]